162 related articles for article (PubMed ID: 9376599)
1. A high pretreatment serum vascular endothelial growth factor concentration is associated with poor outcome in non-Hodgkin's lymphoma.
Salven P; Teerenhovi L; Joensuu H
Blood; 1997 Oct; 90(8):3167-72. PubMed ID: 9376599
[TBL] [Abstract][Full Text] [Related]
2. Simultaneous elevation in the serum concentrations of the angiogenic growth factors VEGF and bFGF is an independent predictor of poor prognosis in non-Hodgkin lymphoma: a single-institution study of 200 patients.
Salven P; Orpana A; Teerenhovi L; Joensuu H
Blood; 2000 Dec; 96(12):3712-8. PubMed ID: 11090051
[TBL] [Abstract][Full Text] [Related]
3. Simultaneous elevation of the serum concentrations of vascular endothelial growth factor and interleukin-6 as independent predictors of prognosis in aggressive non-Hodgkin's lymphoma.
Niitsu N; Okamato M; Nakamine H; Yoshino T; Tamaru J; Nakamura S; Higashihara M; Hirano M
Eur J Haematol; 2002 Feb; 68(2):91-100. PubMed ID: 12038454
[TBL] [Abstract][Full Text] [Related]
4. Elevated serum endostatin is associated with poor outcome in patients with non-Hodgkin lymphoma.
Bono P; Teerenhovi L; Joensuu H
Cancer; 2003 Jun; 97(11):2767-75. PubMed ID: 12767089
[TBL] [Abstract][Full Text] [Related]
5. High pre-treatment serum level of vascular endothelial growth factor (VEGF) is associated with poor outcome in small-cell lung cancer.
Salven P; Ruotsalainen T; Mattson K; Joensuu H
Int J Cancer; 1998 Apr; 79(2):144-6. PubMed ID: 9583728
[TBL] [Abstract][Full Text] [Related]
6. Angiogenic growth factors and endostatin in non-Hodgkin's lymphoma.
Gunsilius E; Petzer AL; Gastl G
Br J Haematol; 2000 Mar; 108(3):661-3. PubMed ID: 10847704
[No Abstract] [Full Text] [Related]
7. Major surgery increases serum levels of vascular endothelial growth factor only temporarily.
Bondestam J; Salven P; Jääskela-Saari H; Ikonen T; Lepäntalo M; Mattila S; Joensuu H
Am J Surg; 2000 Jan; 179(1):57-9. PubMed ID: 10737580
[TBL] [Abstract][Full Text] [Related]
8. Low hemoglobin is associated with increased serum levels of vascular endothelial growth factor (VEGF) in cancer patients. Does anemia stimulate angiogenesis?
Dunst J; Pigorsch S; Hänsgen G; Hintner I; Lautenschläger C; Becker A
Strahlenther Onkol; 1999 Mar; 175(3):93-6. PubMed ID: 10093609
[TBL] [Abstract][Full Text] [Related]
9. Serum vascular endothelial growth factor in epithelial ovarian neoplasms: correlation with patient survival.
Chen CA; Cheng WF; Lee CN; Chen TM; Kung CC; Hsieh FJ; Hsieh CY
Gynecol Oncol; 1999 Aug; 74(2):235-40. PubMed ID: 10419737
[TBL] [Abstract][Full Text] [Related]
10. Vascular endothelial growth factor in the serum of patients with non-small cell lung cancer: correlation with platelet and leukocyte counts.
Choi JH; Kim HC; Lim HY; Nam DK; Kim HS; Yi JW; Chun M; Oh YT; Kang S; Park KJ; Hwang SC; Lee YH; Hahn MH
Lung Cancer; 2001; 33(2-3):171-9. PubMed ID: 11551412
[TBL] [Abstract][Full Text] [Related]
11. Vascular endothelial growth factor in the sera and effusions of patients with malignant and nonmalignant disease.
Kraft A; Weindel K; Ochs A; Marth C; Zmija J; Schumacher P; Unger C; Marmé D; Gastl G
Cancer; 1999 Jan; 85(1):178-87. PubMed ID: 9921991
[TBL] [Abstract][Full Text] [Related]
12. Clinical significance of serum vascular endothelial growth factor in esophageal squamous cell carcinoma.
Shimada H; Takeda A; Nabeya Y; Okazumi SI; Matsubara H; Funami Y; Hayashi H; Gunji Y; Kobayashi S; Suzuki T; Ochiai T
Cancer; 2001 Aug; 92(3):663-9. PubMed ID: 11505413
[TBL] [Abstract][Full Text] [Related]
13. Serum vascular endothelial growth factor levels are elevated in metastatic differentiated thyroid cancer but not increased by short-term TSH stimulation.
Tuttle RM; Fleisher M; Francis GL; Robbins RJ
J Clin Endocrinol Metab; 2002 Apr; 87(4):1737-42. PubMed ID: 11932308
[TBL] [Abstract][Full Text] [Related]
14. A high pretreatment serum basic fibroblast growth factor concentration is an independent predictor of poor prognosis in non-Hodgkin's lymphoma.
Salven P; Teerenhovi L; Joensuu H
Blood; 1999 Nov; 94(10):3334-9. PubMed ID: 10552942
[TBL] [Abstract][Full Text] [Related]
15. Serum levels of vascular endothelial growth factor in patients with head and neck cancer.
Riedel F; Götte K; Schwalb J; Wirtz H; Bergler W; Hörmann K
Eur Arch Otorhinolaryngol; 2000; 257(6):332-6. PubMed ID: 10993554
[TBL] [Abstract][Full Text] [Related]
16. Serum vascular endothelial growth factor is often elevated in disseminated cancer.
Salven P; Mänpää H; Orpana A; Alitalo K; Joensuu H
Clin Cancer Res; 1997 May; 3(5):647-51. PubMed ID: 9815732
[TBL] [Abstract][Full Text] [Related]
17. Circulating levels of vascular endothelial growth factor in patients with oral squamous cell carcinoma.
Shang ZJ; Li JR; Li ZB
Int J Oral Maxillofac Surg; 2002 Oct; 31(5):495-8. PubMed ID: 12418564
[TBL] [Abstract][Full Text] [Related]
18. Vascular endothelial growth factor (VEGF) serum concentration changes during chemotherapy in patients with lung cancer.
Kido Y
Kurume Med J; 2001; 48(1):43-7. PubMed ID: 11402619
[TBL] [Abstract][Full Text] [Related]
19. Leukocytes and platelets of patients with cancer contain high levels of vascular endothelial growth factor.
Salven P; Orpana A; Joensuu H
Clin Cancer Res; 1999 Mar; 5(3):487-91. PubMed ID: 10100697
[TBL] [Abstract][Full Text] [Related]
20. Serum VEGF levels in women with a benign breast tumor or breast cancer.
Salven P; Perhoniemi V; Tykkä H; Mäenpää H; Joensuu H
Breast Cancer Res Treat; 1999 Jan; 53(2):161-6. PubMed ID: 10326793
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
